Delivering better every day health with Nick Tate from Haleon

In this episode, Nick Tate, Head of NEXT – Haleon’s innovation arm, shares his perspective on the success criteria for launching new products and brands in consumer healthcare.

Haleon is one of the world’s leading consumer health businesses, owning category leading brands like Nicorette, Advil, Voltaren and Sonsodyne.

Nick and Vincent discuss the impact of AI on brands and businesses. Tate emphasizes the transformation brought by generative and interactive AI, emphasizing the need for brands to be more responsive and personalized. Tate highlights the role of AI in improving back-office functions such as legal and regulatory processes, as well as creating delightful experiences for consumers. He also stresses the importance of human involvement, stating that great technology should help humans become more human and enable a symbiotic relationship between humans and machines. Tate also shares his personal journey into innovation, driven by a passion for problem-solving and creativity in business. He expresses a strong belief in the value of asking provocative questions and aligning people to solve problems in a determined way.